Evidence map›Paper›PMID 36615837›Full record

Trial reportNutrients2022

Vitamin D3 Supplementation at 5000 IU Daily for the Prevention of Influenza-like Illness in Healthcare Workers: A Pragmatic Randomized Clinical Trial.

Noud van Helmond, Tracy L Brobyn, Patrick J LaRiccia, Teresa Cafaro, Krystal Hunter, Satyajeet Roy, Brigid Bandomer, Kevin Q Ng, Helen Goldstein, Ludmil V Mitrev and 4 more

Open access · goldAbstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 5 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 5 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Noud van HelmondDepartment of Anesthesiology, Cooper University Health Care, Camden, NJ 08103, USA.
Tracy L BrobynCooper Medical School of Rowan University, Camden, NJ 08103, USA.
Patrick J LaRicciaWon Sook Chung Foundation, Moorestown, NJ 08057, USA.
Teresa CafaroDepartment of Anesthesiology, Cooper University Health Care, Camden, NJ 08103, USA.ORCID 0000-0002-8963-9075
Krystal HunterCooper Medical School of Rowan University, Camden, NJ 08103, USA.
Satyajeet RoyCooper Medical School of Rowan University, Camden, NJ 08103, USA.
Brigid BandomerWon Sook Chung Foundation, Moorestown, NJ 08057, USA.ORCID 0000-0002-4010-2488
Kevin Q NgThe Chung Institute of Integrative Medicine, Moorestown, NJ 08057, USA.
Helen GoldsteinWon Sook Chung Foundation, Moorestown, NJ 08057, USA.
Ludmil V MitrevDepartment of Anesthesiology, Cooper University Health Care, Camden, NJ 08103, USA.ORCID 0000-0002-6261-9816
Alan TsaiCooper Medical School of Rowan University, Camden, NJ 08103, USA.
Denise ThwingWon Sook Chung Foundation, Moorestown, NJ 08057, USA.
Mary Ann MaagWon Sook Chung Foundation, Moorestown, NJ 08057, USA.
Myung K ChungCooper Medical School of Rowan University, Camden, NJ 08103, USA.
Cooper Medical School of Rowan University · USCooper University Health Care · USIntegrative Medicine Institute · USUniversity of Pennsylvania · US

Funding

Res-Q Vital D3, N3 Oceanic Inc, Pennsburg, Pennsylvania, USA n/aWon Sook Chung Foundation, Moorestown, NJ USA 310500749
6 · The paper itself

Abstract

Vitamin D supplementation has been shown to reduce the incidence of acute respiratory infections in populations at risk. The COVID-19 pandemic has highlighted the importance of preventing viral infections in healthcare workers. The aim of this study was to assess the hypothesis that vitamin D3 supplementation at 5000 IU daily reduces influenza-like illness (ILI), including COVID-19, in healthcare workers. We conducted a prospective, controlled trial at a tertiary university hospital. A random group of healthcare workers was invited to receive 5000 IU daily vitamin D3 supplementation for nine months, while other random healthcare system workers served as controls. All healthcare workers were required to self-monitor and report to employee health for COVID-19 testing when experiencing symptoms of ILI. COVID-19 test results were retrieved. Incidence rates were compared between the vitamin D and control groups. Workers in the intervention group were included in the analysis if they completed at least 2 months of supplementation to ensure adequate vitamin D levels. The primary analysis compared the incidence rate of all ILI, while secondary analyses examined incidence rates of COVID-19 ILI and non-COVID-19 ILI. Between October 2020 and November 2021, 255 healthcare workers (age 47 ± 12 years, 199 women) completed at least two months of vitamin D3 supplementation. The control group consisted of 2827 workers. Vitamin D3 5000 IU supplementation was associated with a lower risk of ILI (incidence rate difference: -1.7 × 10

Indexed as

COVID-19Influenza, HumanVirus DiseasesAdultCholecalciferolCOVID-19 TestingDietary SupplementsDouble-Blind MethodFemaleHealth PersonnelHumansMiddle AgedPandemicsProspective StudiesVitamin DVitaminsCholecalciferolVitamin DVitaminsCOVID-19healthcare workershospital workersinfluenza-like illnessrandomized clinical trialvitamin D

Identifiers

PMID36615837
PMCPMC9823308
OpenAlexW4313473218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.